Literature DB >> 15278754

The significance of IgA class of antineutrophil cytoplasmic antibodies (ANCA) in childhood Henoch-Schönlein purpura.

Fatih Ozaltin1, Aysin Bakkaloglu, Seza Ozen, Rezan Topaloglu, Umut Kavak, Mukaddes Kalyoncu, Nesrin Besbas.   

Abstract

Antineutrophil cytoplasmic antibodies (ANCA) have been identified in a wide variety of vasculitic disorders, but it is controversial whether ANCA are present in the sera of patients with HSP. This prospective study was designed to assess the place of ANCA, particularly their IgA subclass, in HSP. Thirty-five patients (18 boys, 17 girls) aged 9.4 +/- 4 (3-16) years with a clinical diagnosis of HSP based on American College of Rheumatology (ACR) criteria were enrolled. Thirteen patients (6 boys, 7 girls) aged 8.3 +/- 5.5 (2-21) years with other vasculitides, consisting of classic polyarteritis nodosa (PAN) (n = 2); cutaneous polyarteritis nodosa (n = 1); acute infantile hemorrhagic edema (n = 2); acute urticarial vasculitis (n = 2); hypocomplementemic vasculitis (n = 1); and unclassified vasculitis (n = 5) served as disease controls and 10 healthy children served as normal controls. Twenty-five HSP patients and 7 disease controls were re-evaluated in the resolution phase that was described as 4-6 weeks after all symptoms subsided and all medications were stopped. Blood samples for ANCA and IgA rheumatoid factor (RF) were studied by indirect immunofluorescence (IIF) and ELISA, respectively. IgG ANCA was significantly lower in percentage in HSP patients (2.8%) than in disease controls (40%) (p = 0.002). In contrast, IgA ANCA in cytoplasmic pattern was detected in a significantly higher percentage of HSP patients (82.3%) in the acute phase compared to those in the disease controls (38%) (p = 0.004). In the resolution phase, IgA ANCA was negative in 88% of the patients (p = 0.001 for acute vs resolution phases). Neither IgG nor IgA ANCA were seen in normal controls. No relationship was found between disease severity of HSP and IgA ANCA. Positive IgA rheumatoid factor was present in only two patients with HSP. In conclusion, our results suggest that IgA ANCA may be useful to confirm the diagnosis of HSP in children.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15278754     DOI: 10.1007/s10067-004-0910-y

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  15 in total

Review 1.  The spectrum of vasculitis in children.

Authors:  S Ozen
Journal:  Best Pract Res Clin Rheumatol       Date:  2002-07       Impact factor: 4.098

2.  Diagnostic predictive value of ANCA serology.

Authors:  J C Jennette; A S Wilkman; R J Falk
Journal:  Kidney Int       Date:  1998-03       Impact factor: 10.612

3.  IgA antibodies directed against cytoplasmic antigens of polymorphonuclear leukocytes in patients with Henoch-Schoenlein purpura.

Authors:  A W vd Wall Bake; S Lobatto; L Jonges; M R Daha; L A van Es
Journal:  Adv Exp Med Biol       Date:  1987       Impact factor: 2.622

4.  Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis.

Authors:  C O Savage; C G Winearls; S Jones; P D Marshall; C M Lockwood
Journal:  Lancet       Date:  1987-06-20       Impact factor: 79.321

Review 5.  Specificity and pathogenicity of antineutrophil cytoplasm antibodies.

Authors:  C M Lockwood
Journal:  Exp Nephrol       Date:  1993 Jan-Feb

6.  Properties of circulating IgA molecules in Henoch-Schönlein purpura nephritis with focus on neutrophil cytoplasmic antigen IgA binding (IgA-ANCA): new insight into a debated issue. Italian Group of Renal Immunopathology Collaborative Study on Henoch-Schönlein purpura in adults and in children.

Authors:  R Coppo; P Cirina; A Amore; R A Sinico; A Radice; C Rollino
Journal:  Nephrol Dial Transplant       Date:  1997-11       Impact factor: 5.992

7.  Absence of anti-neutrophil cytoplasmic antibody (ANCA) in Henoch-Schönlein purpura and immunoglobulin A nephropathy.

Authors:  K Kaneko; Y Suzuki; K Yabuta
Journal:  Acta Paediatr Jpn       Date:  1994-12

8.  IgA antineutrophil cytoplasmic antibody in Henoch-Schönlein purpura.

Authors:  F T Saulsbury; P R Kirkpatrick; W K Bolton
Journal:  Am J Nephrol       Date:  1991       Impact factor: 3.754

9.  Lack of IgA antineutrophil cytoplasmic antibodies in Henoch-Schönlein purpura and IgA nephropathy.

Authors:  R A Sinico; M Tadros; A Radice; C Pozzi; M Quarenghi; C Comotti; G Gregorini; A Castiglione; G Arrigo; G D'Amico
Journal:  Clin Immunol Immunopathol       Date:  1994-10

10.  Antineutrophil cytoplasm antibodies (ANCA) of IgA isotype in adult Henoch-Schönlein purpura.

Authors:  N Ronda; V L Esnault; L Layward; V Sepe; A Allen; J Feehally; C M Lockwood
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

View more
  10 in total

1.  IgA and IgG antineutrophil cytoplasmic antibody engagement of Fc receptor genetic variants influences granulomatosis with polyangiitis.

Authors:  James M Kelley; Paul A Monach; Chuanyi Ji; Yebin Zhou; Jianming Wu; Sumiaki Tanaka; Alfred D Mahr; Sharleen Johnson; Carol McAlear; David Cuthbertson; Simon Carette; John C Davis; Paul F Dellaripa; Gary S Hoffman; Nader Khalidi; Carol A Langford; Phillip Seo; E William St Clair; Ulrich Specks; John H Stone; Robert F Spiera; Steven R Ytterberg; Peter A Merkel; Jeffrey C Edberg; Robert P Kimberly
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-06       Impact factor: 11.205

2.  A child with arthritis, skin rash, abdominal pain and nephritis: searching beyond Henoch-Schönlein purpura-Answers.

Authors:  William Chotas; Mohammad Ilyas; Asad Tolaymat
Journal:  Pediatr Nephrol       Date:  2018-07-27       Impact factor: 3.714

3.  IgA antibodies to myeloperoxidase in patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss).

Authors:  Esha Oommen; Amber Hummel; Lisa Allmannsberger; David Cuthbertson; Simon Carette; Christian Pagnoux; Gary S Hoffman; Dieter E Jenne; Nader A Khalidi; Curry L Koening; Carol A Langford; Carol A McAlear; Larry Moreland; Philip Seo; Antoine Sreih; Steven R Ytterberg; Peter A Merkel; Ulrich Specks; Paul A Monach
Journal:  Clin Exp Rheumatol       Date:  2017-03-01       Impact factor: 4.473

Review 4.  Adult-onset Henoch-Schonlein purpura with positive c-ANCA (anti-proteinase 3): case report and review of literature.

Authors:  Eman Boulis; Vikas Majithia; Robert McMurray
Journal:  Rheumatol Int       Date:  2010-10-21       Impact factor: 2.631

Review 5.  Clinical practice: Diagnosis and management of Henoch-Schönlein purpura.

Authors:  Hugh J McCarthy; E Jane Tizard
Journal:  Eur J Pediatr       Date:  2009-12-12       Impact factor: 3.183

6.  Significance of antineutrophil cytoplasmic antibody in adult patients with Henoch-Schönlein purpura presenting mainly with gastrointestinal symptoms.

Authors:  Yan Zhang; Yong-Kang Wu; Matthew-A Ciorba; Qin Ouyang
Journal:  World J Gastroenterol       Date:  2008-01-28       Impact factor: 5.742

Review 7.  Wegener's granulomatosis: a model of auto-antibodies in mucosal autoimmunity.

Authors:  James M Kelley; Jeffrey C Edberg; Robert P Kimberly
Journal:  Clin Immunol       Date:  2009-05-23       Impact factor: 3.969

Review 8.  Multicentric Castleman's disease associated with IgA vasculitis (Henoch-Schönlein purpura) responding well to tocilizumab: a case report.

Authors:  Yoichi Oshima; Junichi Hoshino; Tatsuya Suwabe; Noriko Hayami; Masayuki Yamanouchi; Akinari Sekine; Toshiharu Ueno; Hiroki Mizuno; Junko Yabuuchi; Aya Imafuku; Masahiro Kawada; Rikako Hiramatsu; Eiko Hasegawa; Naoki Sawa; Kenmei Takaichi; Nobukazu Hayashi; Takeshi Fujii; Yoshifumi Ubara
Journal:  Clin Rheumatol       Date:  2017-02-06       Impact factor: 3.650

9.  IgA Vasculitis Without Typical Skin Rash Concomitated With c-ANCA Positivity.

Authors:  Mohamed W Abukhatwah; Naglaa M Kamal; Muteb K Altowairqi; Wejdan A Alzahrani; Shaher A Alsuwat; Ahmed Soliman
Journal:  Clin Med Insights Case Rep       Date:  2022-02-25

Review 10.  IgA vasculitis update: Epidemiology, pathogenesis, and biomarkers.

Authors:  Liyun Xu; Yongzhen Li; Xiaochuan Wu
Journal:  Front Immunol       Date:  2022-10-03       Impact factor: 8.786

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.